Search

AxoGen Inc

Chiusa

SettoreSettore sanitario

41.79 -0.14

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

41.61

Massimo

42.51

Metriche Chiave

By Trading Economics

Entrata

18M

-1.5M

Vendite

8.3M

70M

EPS

-0.03

Margine di Profitto

-2.174

Dipendenti

622

EBITDA

15M

-2.2M

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+30.16% upside

Dividendi

By Acuity

Utili prossimi

28 ott 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

408M

2.6B

Apertura precedente

41.93

Chiusura precedente

41.79

Notizie sul Sentiment di mercato

By Acuity

50%

50%

126 / 339 Classifica in Healthcare

AxoGen Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

11 set 2026, 20:13 UTC

AxoGen Inc shares are lower in after-market hours with no specific news identified. Recent inflation data has raised speculation about a Federal Reserve rate hike.

10 set 2026, 20:03 UTC

News
Social Media
Event

AxoGen Inc shares are lower after announcing a public offering of 4.91 million shares at $42.50 to fund its $200 million acquisition of BioCircuit Technologies.

8 set 2026, 20:07 UTC

News

AxoGen Inc shares are lower today, continuing a downward trend amid speculation of an interest rate hike following a stronger-than-expected jobs report.

3 set 2026, 19:56 UTC

AxoGen Inc shares are lower, extending a five-session decline amid broader market dynamics and a drop in Treasury yields following jobless claims data.

2 set 2026, 20:01 UTC

AxoGen Inc shares are lower today, marking four consecutive sessions of declines. Broader market sentiment is affected by a disappointing ADP employment report.

1 set 2026, 20:09 UTC

News

AxoGen Inc shares are lower today, continuing a decline since Monday amid rising oil prices and inflation concerns affecting the health care equipment sector.

31 ago 2026, 21:01 UTC

AxoGen Inc shares are higher in after-market trading, reflecting positive momentum despite no specific company news. Broader market sentiment is influenced by Fed Chair Warsh's remarks.

28 ago 2026, 23:01 UTC

AxoGen Inc shares are higher in after-market trading, reflecting positive momentum. The stock is near the upper end of its one-month trading range.

27 ago 2026, 19:56 UTC

News

AxoGen shares are higher as Bamco Inc. acquired 740,210 shares valued at $34.19 million in the second quarter, boosting institutional sentiment.

26 ago 2026, 23:01 UTC

AxoGen Inc shares are higher in after-market trading, reflecting broader market trends and positive macroeconomic data indicating underlying economic strength.

25 ago 2026, 19:46 UTC

AxoGen Inc shares are higher during Tuesday's session, reflecting upward momentum amid broader positive trends in equities and a favorable health care equipment sector.

24 ago 2026, 21:01 UTC

AxoGen Inc shares are higher in after-market trading, maintaining gains since Monday's close and positioned near the upper end of their one-month range.

21 ago 2026, 20:01 UTC

AxoGen Inc shares are higher today, supported by high trading volume. The stock remains above its 20-day moving average amid broader market gains.

20 ago 2026, 22:46 UTC

AxoGen Inc shares are higher in after-market trading, showing notable strength above the 20-day moving average and near the upper end of its one-month range.

19 ago 2026, 21:01 UTC

AxoGen Inc shares are lower in after-market trading, despite no specific news to explain the decline. The stock remains near its one-month high.

18 ago 2026, 19:16 UTC

AxoGen Inc shares are higher, continuing positive momentum from Monday. The stock remains above its 20-day moving average, reflecting strong performance.

17 ago 2026, 21:01 UTC

AxoGen Inc shares are higher in after-market trading, reaching a peak above Monday's close amid broader market pressures and rising crude oil prices.

14 ago 2026, 20:06 UTC

AxoGen Inc's shares are higher today amid mixed market sentiment following a decline in U.S. retail sales for July. No specific company news was identified.

13 ago 2026, 22:36 UTC

AxoGen Inc. shares declined in after-market trading, despite broader market strength and earlier gains. The stock remains above recent performance averages.

12 ago 2026, 19:32 UTC

AxoGen Inc shares are higher today amid strong trading volume and broader market gains, reflecting optimism from recent inflation data.

10 ago 2026, 19:41 UTC

AxoGen Inc shares are higher, driven by gains in the Health Care Equipment sub-sector and unusually high market volume. The stock remains above its 20-day moving average.

7 ago 2026, 20:05 UTC

AxoGen Inc shares are higher today amid strong market volume, reflecting a broader upward trend since Thursday's close.

5 ago 2026, 19:46 UTC

AxoGen Inc shares are lower amid broader market caution following ADP's report of a significant miss in private sector job growth for July.

4 ago 2026, 20:06 UTC

AxoGen Inc's shares are higher today, continuing a steady climb since Monday's close amid positive market sentiment and broader trends.

3 ago 2026, 20:02 UTC

News

AxoGen Inc. shares are advancing as trading volume spikes amid strong interest. The company reported a 23.1% revenue increase to $69.7 million for Q2 2026.

31 lug 2026, 20:06 UTC

AxoGen Inc shares are higher, recovering from an earlier dip. The stock remains above its 20-day moving average, reflecting solid overall performance.

30 lug 2026, 19:24 UTC

AxoGen Inc shares are higher, supported by significant broader market gains and unusually high trading volume, despite earlier pulling back from session highs.

29 lug 2026, 20:41 UTC

AxoGen Inc shares are lower in after-market trading amid a broader downturn in U.S. equities and rising crude oil prices linked to geopolitical tensions.

28 lug 2026, 20:03 UTC

AxoGen Inc. shares are declining today, pulling back from an earlier high amid broader market weakness linked to declines in Asian indices.

27 lug 2026, 19:16 UTC

AxoGen Inc shares are higher today, continuing a strong upward trend since Friday's close. Broader market sentiment is influenced by declining oil prices.

Confronto tra pari

Modifica del prezzo

AxoGen Inc Previsione

Obiettivo di Prezzo

By TipRanks

30.16% in crescita

Previsioni per 12 mesi

Media 54.875 USD  30.16%

Alto 60 USD

Basso 48 USD

Basato su 8 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per AxoGen Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

8 ratings

8

Acquista

0

Mantieni

0

Vendi

Sentiment

By Acuity

126 / 339 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Neutral

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo AxoGen Inc

Axogen, Inc., together with its subsidiaries, develops and commercializes technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments; and Axoguard HA+ Nerve Protector, a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating designed to provide short- and long-term protection for peripheral nerve injuries. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and AxoTouch two-point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals, plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. Axogen, Inc. is headquartered in Alachua, Florida.
help-icon Live chat